Biomarker Testing Services Market by Services, Techonology, Disease Area, Application, End-User - Global Forecast 2025-2030- Product Image

Sale

Biomarker Testing Services Market by Services, Techonology, Disease Area, Application, End-User - Global Forecast 2025-2030

Report
182 Pages
October 2024
Region: Global
360iResearch™
ID: 5715912

UP TO €692EUR$697USD£576GBP OFF until Dec 31^st 2024

The Biomarker Testing Services Market grew from USD 964.90 million in 2023 to USD 1.03 billion in 2024. It is expected to continue growing at a CAGR of 7.34%, reaching USD 1.58 billion by 2030.

Biomarker testing services encompass a broad range of diagnostic examinations that identify biological indicators often used in disease diagnosis, prognosis, and treatment monitoring. This includes genomic, proteomic, and metabolic markers that can guide personalized medical approaches. The necessity of biomarker testing arises from its ability to provide precise diagnostic information, leading to tailored treatment regimens; this application is especially crucial in oncology, cardiovascular diseases, and neurology. End-use scope prominently covers hospitals, diagnostic laboratories, and research institutes, which rely on these services to enhance patient care outcomes and accelerate clinical research. The market for biomarker testing services is predominantly driven by technological advancements in genomic sequencing, increasing prevalence of chronic diseases, and a shift towards personalized medicine. Developing economies present burgeoning opportunities due to rising healthcare expenditure and increasing adoption of advanced diagnostics. Furthermore, collaborations between biotech firms and healthcare providers offer substantial growth prospects. However, high costs of testing, regulatory hurdles, and varied reimbursement scenarios pose significant challenges. Additionally, data privacy concerns and the complexity of biomarker validation are potential limitations hindering market expansion. To capitalize on growth prospects, innovation could be directed towards cost-effective, high-throughput diagnostic technologies and integrated bioinformatics platforms that offer comprehensive data analysis. Emerging AI and machine learning technologies also present promising avenues for enhancing diagnostic accuracy and efficiency. Ensuring compliance with regulatory frameworks while fostering clarity on reimbursement policies will be critical for market maturation. The nature of the biomarker testing services market is highly dynamic, characterized by rapid technological evolution and robust competition. Future research should focus on expanding biomarker panels and diversifying their applications across various medical domains to ensure continued innovation and competitive advantage in this evolving landscape.

Understanding Market Dynamics in the Biomarker Testing Services Market

The Biomarker Testing Services Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.

Market Drivers
- Increasing cancer drug development and need for high-performing biomarkers
- Government initiatives and investments for biomarker research
- Improved availability of financial coverage for biomarker testing
Market Restraints
- Time-consuming and expensive process of biomarker testing
Market Opportunities
- Advancements in biomarker testing tools & equipment with AI & ML
- Emerging CDMOs offering biomarker testing and analysis services
Market Challenges
- Barriers in testing due to lack of sample collection and authenticity

Exploring Porter’s Five Forces for the Biomarker Testing Services Market

Porter’s Five Forces framework further strengthens the insights of the Biomarker Testing Services Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Biomarker Testing Services Market

External macro-environmental factors deeply influence the performance of the Biomarker Testing Services Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Biomarker Testing Services Market

The Biomarker Testing Services Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Biomarker Testing Services Market

The Biomarker Testing Services Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the Biomarker Testing Services Market

The Biomarker Testing Services Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the Biomarker Testing Services Market, highlighting leading vendors and their innovative profiles. These include Abcam PLC by Danaher Corporation, Agilent Technologies, Inc., Avid Bioservices, Inc., Bio-Rad Laboratories, Inc., BioAgilytix Labs, BiomarkerBay B. V., Bristol Myers Squibb, Eurofins Scientific SE, F. Hoffmann-La Roche AG, Icon PLC, Intertek Group PLC, IQVIA, JSR Life Sciences, LLC, KCAS Group, Laboratory Corporation of America Holdings, LGC Group, Merck KGaA, Myriad Genetics, Inc., NeoGenomics Laboratories, Parexel International Corporation, PerkinElmer Inc., Randox Laboratories, SGS S.A., Shuwen Biotech Co., Ltd., Syneos Health, Thermo Fisher Scientific, Inc., and WuXi Biologics Inc..

Market Segmentation & Coverage

This research report categorizes the Biomarker Testing Services Market to forecast the revenues and analyze trends in each of the following sub-markets:

Services
- Biomarker Assay Development & Validation
- Flow Cytometry
Techonology
- Enzyme-Linked Immunosorbent Assay
- Mass Spectrometry
- Next-Generation Sequencing
- Polymerase Chain Reaction
Disease Area
- Autoimmune Diseases
- Cancer
- Cardiovascular Diseases
- Neurological Disorders
Application
- Drug Mechanism of Action
- Pharmacodynamic
- Predictive Clinical Studies
- Prognostic
End-User
- Contract Research Oraganizations
- Pharmaceutical & biotechnology companies
- Research Institutes

Region
- Americas
  - Argentina
  - Brazil
  - Canada
  - Mexico
  - United States
    - California
    - Florida
    - Illinois
    - New York
    - Ohio
    - Pennsylvania
    - Texas
- Asia-Pacific
  - Australia
  - China
  - India
  - Indonesia
  - Japan
  - Malaysia
  - Philippines
  - Singapore
  - South Korea
  - Taiwan
  - Thailand
  - Vietnam
- Europe, Middle East & Africa
  - Denmark
  - Egypt
  - Finland
  - France
  - Germany
  - Israel
  - Italy
  - Netherlands
  - Nigeria
  - Norway
  - Poland
  - Qatar
  - Russia
  - Saudi Arabia
  - South Africa
  - Spain
  - Sweden
  - Switzerland
  - Turkey
  - United Arab Emirates
  - United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

What is the current size of the market, and how is it expected to grow?
Which products, segments, and regions present the most attractive investment opportunities?
What are the prevailing technology trends and regulatory factors influencing the market?
How do top vendors rank regarding market share and competitive positioning?
What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary
4. Market Overview

5. Market Insights

5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing cancer drug development and need for high-performing biomarkers
5.1.1.2. Government initiatives and investments for biomarker research
5.1.1.3. Improved availability of financial coverage for biomarker testing
5.1.2. Restraints
5.1.2.1. Time-consuming and expensive process of biomarker testing
5.1.3. Opportunities
5.1.3.1. Advancements in biomarker testing tools & equipment with AI & ML
5.1.3.2. Emerging CDMOs offering biomarker testing and analysis services
5.1.4. Challenges
5.1.4.1. Barriers in testing due to lack of sample collection and authenticity
5.2. Market Segmentation Analysis
5.2.1. Technology: Ongoing advancements to improve the versatility, speed, and amplification capabilities of polymerase chain reaction technology
5.2.2. End-User: Emerging utilization of biomarker testing services by pharmaceutical & biotechnology companies for therapeutic interventions
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental

6. Biomarker Testing Services Market, by Services

6.1. Introduction
6.2. Biomarker Assay Development & Validation
6.3. Flow Cytometry

7. Biomarker Testing Services Market, by Techonology

7.1. Introduction
7.2. Enzyme-Linked Immunosorbent Assay
7.3. Mass Spectrometry
7.4. Next-Generation Sequencing
7.5. Polymerase Chain Reaction

8. Biomarker Testing Services Market, by Disease Area

8.1. Introduction
8.2. Autoimmune Diseases
8.3. Cancer
8.4. Cardiovascular Diseases
8.5. Neurological Disorders

9. Biomarker Testing Services Market, by Application

9.1. Introduction
9.2. Drug Mechanism of Action
9.3. Pharmacodynamic
9.4. Predictive Clinical Studies
9.5. Prognostic

10. Biomarker Testing Services Market, by End-User

10.1. Introduction
10.2. Contract Research Oraganizations
10.3. Pharmaceutical & biotechnology companies
10.4. Research Institutes

11. Americas Biomarker Testing Services Market

11.1. Introduction
11.2. Argentina
11.3. Brazil
11.4. Canada
11.5. Mexico
11.6. United States

12. Asia-Pacific Biomarker Testing Services Market

12.1. Introduction
12.2. Australia
12.3. China
12.4. India
12.5. Indonesia
12.6. Japan
12.7. Malaysia
12.8. Philippines
12.9. Singapore
12.10. South Korea
12.11. Taiwan
12.12. Thailand
12.13. Vietnam

13. Europe, Middle East & Africa Biomarker Testing Services Market

13.1. Introduction
13.2. Denmark
13.3. Egypt
13.4. Finland
13.5. France
13.6. Germany
13.7. Israel
13.8. Italy
13.9. Netherlands
13.10. Nigeria
13.11. Norway
13.12. Poland
13.13. Qatar
13.14. Russia
13.15. Saudi Arabia
13.16. South Africa
13.17. Spain
13.18. Sweden
13.19. Switzerland
13.20. Turkey
13.21. United Arab Emirates
13.22. United Kingdom

14. Competitive Landscape

14.1. Market Share Analysis, 2023
14.2. FPNV Positioning Matrix, 2023
14.3. Competitive Scenario Analysis
14.3.1. Mayo Clinic Laboratories and Progentec Collaborate To Bring Advanced Biomarker Testing Services To Patients With Autoimmune Diseases
14.3.2. Novel Prostate Cancer Biomarker Test Launches on US Market
14.3.3. Quanterix Launches LucentAD Biomarker Blood Test To Aid Physician Diagnosis of Alzheimer’s Disease In Patients
14.4. Strategy Analysis & Recommendation

List of Figures

FIGURE 1. BIOMARKER TESTING SERVICES MARKET RESEARCH PROCESS
FIGURE 2. BIOMARKER TESTING SERVICES MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2023 VS 2030 (%)
FIGURE 7. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2023 VS 2030 (%)
FIGURE 9. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2023 VS 2030 (%)
FIGURE 11. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 13. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 15. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. AMERICAS BIOMARKER TESTING SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 17. AMERICAS BIOMARKER TESTING SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. UNITED STATES BIOMARKER TESTING SERVICES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 19. UNITED STATES BIOMARKER TESTING SERVICES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 20. ASIA-PACIFIC BIOMARKER TESTING SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 21. ASIA-PACIFIC BIOMARKER TESTING SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA BIOMARKER TESTING SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA BIOMARKER TESTING SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 24. BIOMARKER TESTING SERVICES MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 25. BIOMARKER TESTING SERVICES MARKET, FPNV POSITIONING MATRIX, 2023

List of Tables

TABLE 1. BIOMARKER TESTING SERVICES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. BIOMARKER TESTING SERVICES MARKET DYNAMICS
TABLE 7. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY BIOMARKER ASSAY DEVELOPMENT & VALIDATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY FLOW CYTOMETRY, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY ENZYME-LINKED IMMUNOSORBENT ASSAY, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY MASS SPECTROMETRY, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY NEXT-GENERATION SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY AUTOIMMUNE DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY NEUROLOGICAL DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY DRUG MECHANISM OF ACTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY PHARMACODYNAMIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY PREDICTIVE CLINICAL STUDIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY PROGNOSTIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY CONTRACT RESEARCH ORAGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. AMERICAS BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 30. AMERICAS BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2030 (USD MILLION)
TABLE 31. AMERICAS BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
TABLE 32. AMERICAS BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 33. AMERICAS BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 34. AMERICAS BIOMARKER TESTING SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 35. ARGENTINA BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 36. ARGENTINA BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2030 (USD MILLION)
TABLE 37. ARGENTINA BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
TABLE 38. ARGENTINA BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 39. ARGENTINA BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 40. BRAZIL BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 41. BRAZIL BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2030 (USD MILLION)
TABLE 42. BRAZIL BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
TABLE 43. BRAZIL BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 44. BRAZIL BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 45. CANADA BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 46. CANADA BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2030 (USD MILLION)
TABLE 47. CANADA BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
TABLE 48. CANADA BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 49. CANADA BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 50. MEXICO BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 51. MEXICO BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2030 (USD MILLION)
TABLE 52. MEXICO BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
TABLE 53. MEXICO BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 54. MEXICO BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 55. UNITED STATES BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 56. UNITED STATES BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2030 (USD MILLION)
TABLE 57. UNITED STATES BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
TABLE 58. UNITED STATES BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 59. UNITED STATES BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 60. UNITED STATES BIOMARKER TESTING SERVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 61. ASIA-PACIFIC BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 62. ASIA-PACIFIC BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2030 (USD MILLION)
TABLE 63. ASIA-PACIFIC BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
TABLE 64. ASIA-PACIFIC BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 65. ASIA-PACIFIC BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 66. ASIA-PACIFIC BIOMARKER TESTING SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 67. AUSTRALIA BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 68. AUSTRALIA BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2030 (USD MILLION)
TABLE 69. AUSTRALIA BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
TABLE 70. AUSTRALIA BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 71. AUSTRALIA BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 72. CHINA BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 73. CHINA BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2030 (USD MILLION)
TABLE 74. CHINA BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
TABLE 75. CHINA BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 76. CHINA BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 77. INDIA BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 78. INDIA BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2030 (USD MILLION)
TABLE 79. INDIA BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
TABLE 80. INDIA BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 81. INDIA BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 82. INDONESIA BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 83. INDONESIA BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2030 (USD MILLION)
TABLE 84. INDONESIA BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
TABLE 85. INDONESIA BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 86. INDONESIA BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 87. JAPAN BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 88. JAPAN BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2030 (USD MILLION)
TABLE 89. JAPAN BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
TABLE 90. JAPAN BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 91. JAPAN BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 92. MALAYSIA BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 93. MALAYSIA BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2030 (USD MILLION)
TABLE 94. MALAYSIA BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
TABLE 95. MALAYSIA BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 96. MALAYSIA BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 97. PHILIPPINES BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 98. PHILIPPINES BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2030 (USD MILLION)
TABLE 99. PHILIPPINES BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
TABLE 100. PHILIPPINES BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 101. PHILIPPINES BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 102. SINGAPORE BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 103. SINGAPORE BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2030 (USD MILLION)
TABLE 104. SINGAPORE BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
TABLE 105. SINGAPORE BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 106. SINGAPORE BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 107. SOUTH KOREA BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 108. SOUTH KOREA BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2030 (USD MILLION)
TABLE 109. SOUTH KOREA BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
TABLE 110. SOUTH KOREA BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 111. SOUTH KOREA BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 112. TAIWAN BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 113. TAIWAN BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2030 (USD MILLION)
TABLE 114. TAIWAN BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
TABLE 115. TAIWAN BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 116. TAIWAN BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 117. THAILAND BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 118. THAILAND BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2030 (USD MILLION)
TABLE 119. THAILAND BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
TABLE 120. THAILAND BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 121. THAILAND BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 122. VIETNAM BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 123. VIETNAM BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2030 (USD MILLION)
TABLE 124. VIETNAM BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
TABLE 125. VIETNAM BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 126. VIETNAM BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 127. EUROPE, MIDDLE EAST & AFRICA BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 128. EUROPE, MIDDLE EAST & AFRICA BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2030 (USD MILLION)
TABLE 129. EUROPE, MIDDLE EAST & AFRICA BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
TABLE 130. EUROPE, MIDDLE EAST & AFRICA BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 131. EUROPE, MIDDLE EAST & AFRICA BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 132. EUROPE, MIDDLE EAST & AFRICA BIOMARKER TESTING SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 133. DENMARK BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 134. DENMARK BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2030 (USD MILLION)
TABLE 135. DENMARK BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
TABLE 136. DENMARK BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 137. DENMARK BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 138. EGYPT BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 139. EGYPT BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2030 (USD MILLION)
TABLE 140. EGYPT BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
TABLE 141. EGYPT BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 142. EGYPT BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 143. FINLAND BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 144. FINLAND BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2030 (USD MILLION)
TABLE 145. FINLAND BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
TABLE 146. FINLAND BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 147. FINLAND BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 148. FRANCE BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 149. FRANCE BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2030 (USD MILLION)
TABLE 150. FRANCE BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
TABLE 151. FRANCE BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 152. FRANCE BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 153. GERMANY BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 154. GERMANY BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2030 (USD MILLION)
TABLE 155. GERMANY BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
TABLE 156. GERMANY BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 157. GERMANY BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 158. ISRAEL BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 159. ISRAEL BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2030 (USD MILLION)
TABLE 160. ISRAEL BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
TABLE 161. ISRAEL BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 162. ISRAEL BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 163. ITALY BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 164. ITALY BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2030 (USD MILLION)
TABLE 165. ITALY BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
TABLE 166. ITALY BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 167. ITALY BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 168. NETHERLANDS BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 169. NETHERLANDS BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2030 (USD MILLION)
TABLE 170. NETHERLANDS BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
TABLE 171. NETHERLANDS BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 172. NETHERLANDS BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 173. NIGERIA BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 174. NIGERIA BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2030 (USD MILLION)
TABLE 175. NIGERIA BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
TABLE 176. NIGERIA BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 177. NIGERIA BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 178. NORWAY BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 179. NORWAY BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2030 (USD MILLION)
TABLE 180. NORWAY BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
TABLE 181. NORWAY BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 182. NORWAY BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 183. POLAND BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 184. POLAND BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2030 (USD MILLION)
TABLE 185. POLAND BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
TABLE 186. POLAND BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 187. POLAND BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 188. QATAR BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 189. QATAR BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2030 (USD MILLION)
TABLE 190. QATAR BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
TABLE 191. QATAR BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 192. QATAR BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 193. RUSSIA BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 194. RUSSIA BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2030 (USD MILLION)
TABLE 195. RUSSIA BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
TABLE 196. RUSSIA BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 197. RUSSIA BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 198. SAUDI ARABIA BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 199. SAUDI ARABIA BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2030 (USD MILLION)
TABLE 200. SAUDI ARABIA BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
TABLE 201. SAUDI ARABIA BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 202. SAUDI ARABIA BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 203. SOUTH AFRICA BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 204. SOUTH AFRICA BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2030 (USD MILLION)
TABLE 205. SOUTH AFRICA BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
TABLE 206. SOUTH AFRICA BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 207. SOUTH AFRICA BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 208. SPAIN BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 209. SPAIN BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2030 (USD MILLION)
TABLE 210. SPAIN BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
TABLE 211. SPAIN BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 212. SPAIN BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 213. SWEDEN BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 214. SWEDEN BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2030 (USD MILLION)
TABLE 215. SWEDEN BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
TABLE 216. SWEDEN BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 217. SWEDEN BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 218. SWITZERLAND BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 219. SWITZERLAND BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2030 (USD MILLION)
TABLE 220. SWITZERLAND BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
TABLE 221. SWITZERLAND BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 222. SWITZERLAND BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 223. TURKEY BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 224. TURKEY BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2030 (USD MILLION)
TABLE 225. TURKEY BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
TABLE 226. TURKEY BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 227. TURKEY BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 228. UNITED ARAB EMIRATES BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 229. UNITED ARAB EMIRATES BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2030 (USD MILLION)
TABLE 230. UNITED ARAB EMIRATES BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
TABLE 231. UNITED ARAB EMIRATES BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 232. UNITED ARAB EMIRATES BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 233. UNITED KINGDOM BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 234. UNITED KINGDOM BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2030 (USD MILLION)
TABLE 235. UNITED KINGDOM BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
TABLE 236. UNITED KINGDOM BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 237. UNITED KINGDOM BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 238. BIOMARKER TESTING SERVICES MARKET SHARE, BY KEY PLAYER, 2023
TABLE 239. BIOMARKER TESTING SERVICES MARKET, FPNV POSITIONING MATRIX, 2023

Companies Mentioned

The leading players in the Biomarker Testing Services Market, which are profiled in this report, include:

Abcam PLC by Danaher Corporation
Agilent Technologies, Inc.
Avid Bioservices, Inc.
Bio-Rad Laboratories, Inc.
BioAgilytix Labs
BiomarkerBay B. V.
Bristol Myers Squibb
Eurofins Scientific SE
F. Hoffmann-La Roche AG
Icon PLC
Intertek Group PLC
IQVIA
JSR Life Sciences, LLC
KCAS Group
Laboratory Corporation of America Holdings
LGC Group
Merck KGaA
Myriad Genetics, Inc.
NeoGenomics Laboratories
Parexel International Corporation
PerkinElmer Inc.
Randox Laboratories
SGS S.A.
Shuwen Biotech Co., Ltd.
Syneos Health
Thermo Fisher Scientific, Inc.
WuXi Biologics Inc.

Methodology

LOADING...

Table Information

Report Attribute	Details
No. of Pages	182
Published	October 2024
Forecast Period	2024 - 2030
Estimated Market Value ( USD ) in 2024	$ 1.03 Billion
Forecasted Market Value ( USD ) by 2030	$ 1.58 Billion
Compound Annual Growth Rate	7.3%
Regions Covered	Global
No. of Companies Mentioned	27

License	Format	Properties	Price
SINGLE USER LICENSE PDF, Excel and Online Access		This is a single user license, allowing one user access to the product.	€3522EUR$3,545USD£2,928GBP €3913EUR$3,939USD£3,254GBP
ENTERPRISE LICENSE PDF, Excel and Online Access		This is an enterprise license, allowing all employees within your organization access to the product.	€6231EUR$6,272USD£5,181GBP €6923EUR$6,969USD£5,757GBP

Understanding Market Dynamics in the Biomarker Testing Services Market

Exploring Porter’s Five Forces for the Biomarker Testing Services Market

Applying PESTLE Analysis to the Biomarker Testing Services Market

Analyzing Market Share in the Biomarker Testing Services Market

Evaluating Vendor Success with the FPNV Positioning Matrix in the Biomarker Testing Services Market

Strategic Recommendations for Success in the Biomarker Testing Services Market

Key Company Profiles

Market Segmentation & Coverage

The report provides a detailed overview of the market, exploring several key areas:

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

Table of Contents

Companies Mentioned

Methodology

Table Information

Related Topics

Related Reports

Biomarker Testing Services Market Size, Share & Trends Analysis Report By Service (Biomarker Assay Development & Validation, Flow Cytometry), By Type (Molecular Biomarkers, Cellular Biomarkers), By End Use, By Region, And Segment Forecasts, 2024 - 2030

Cardiac Biomarkers Testing Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030

Cardiac Biomarkers Testing Global Market Report 2024

2024 Global Forecast for Pd-L1 Biomarker Testing Platform Market (2025-2030 Outlook)-High Tech & Emerging Markets Report

Cardiac Biomarker Market by Type, Location of Testing, Application - Global Forecast 2025-2030

About the Market